T1a N0M0 Renal Cell Carcinoma: The Floodgate of Incidentally Detected Lesions; the Pandora’s Box of Treatment Options
- 1 March 2026
- journal article
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 318 (3) , e260512
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Ablation and Surgery Show Comparable Long-term Outcomes for T1a Renal Cell Carcinoma: A Danish Nationwide Registry StudyRadiology, 2026
- Active Surveillance vs Primary Intervention for Clinical T1a Kidney Tumors: 12-Year Experience of the Delayed Intervention and Surveillance for Small Renal Masses Prospective Comparative StudyJournal of Urology, 2025
- Durability of Active Surveillance for Localized Renal Masses: 3-year Outcomes in the Michigan Urological Surgery Improvement CollaborativeEuropean Urology Open Science, 2025
- Oncological Outcomes of Active Surveillance versus Surgery or Ablation for Patients with Small Renal Masses: A Systematic Review and Quantitative AnalysisEuropean Urology Oncology, 2024
- Current perspectives on active surveillance for patients with small renal massesAsian Journal of Urology, 2022
- Nordic Health Registry-Based Research: A Review of Health Care Systems and Key RegistriesClinical Epidemiology, 2021
- Percutaneous Microwave Ablation versus Laparoscopic Partial Nephrectomy for cT1a Renal Cell Carcinoma: A Propensity-matched Cohort Study of 1955 PatientsRadiology, 2020
- Ablation versus Resection for Stage 1A Renal Cell Carcinoma: National Variation in Clinical Management and Selected OutcomesRadiology, 2018
- Comparative Effectiveness of Thermal Ablation, Surgical Resection, and Active Surveillance for T1a Renal Cell Carcinoma: A Surveillance, Epidemiology, and End Results (SEER)–Medicare-linked Population StudyRadiology, 2018